Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Nakamura

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|October 22, 2008
[Diagnosis of and therapy for Alzheimer-type dementia]Yu Nakamura
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|December 8, 2009
[Drug therapy for dementia]Yu Nakamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2012
[Severe Impairment Battery (SIB)]Yu Nakamura
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|May 10, 2012
[New anti-AD drugs--their possibilities and issues]Yu Nakamura
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|April 22, 2009
[How long should drug therapy be continued for Alzheimer disease?]Yu Nakamura
Clinical Calcium|January 31, 2015
[Cognitive Function and Calcium. Suppression of neurotoxicity by an anti-dementia drug managing calcium influx]Yu Nakamura, Yasumasa Yoshiyama
Dementia and Geriatric Cognitive Disorders Extra|December 14, 2011
Does the Use of Nursing-Care Services Reduce the Information about Dementia Patients Provided by Their Caregivers?Yu Nakamura, Akira Homma
Geriatrics & Gerontology International|August 23, 2016
Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's diseaseNobuyasu Bando, Yu Nakamura
The Journal of Veterinary Medical Science|April 17, 2018
Tunnel use facilitates handling of ICR mice and decreases experimental variationYu Nakamura, Kaoru Suzuki
Organic Letters|July 1, 2014
Oxidative debenzylation of N-benzyl amides and O-benzyl ethers using alkali metal bromideKatsuhiko Moriyama, Yu Nakamura, Hideo Togo
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|October 22, 2008
[Diagnosis of and therapy for Alzheimer-type dementia]Yu Nakamura
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|December 8, 2009
[Drug therapy for dementia]Yu Nakamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2012
[Severe Impairment Battery (SIB)]Yu Nakamura
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|May 10, 2012
[New anti-AD drugs--their possibilities and issues]Yu Nakamura
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|April 22, 2009
[How long should drug therapy be continued for Alzheimer disease?]Yu Nakamura
Clinical Calcium|January 31, 2015
[Cognitive Function and Calcium. Suppression of neurotoxicity by an anti-dementia drug managing calcium influx]Yu Nakamura, Yasumasa Yoshiyama
Dementia and Geriatric Cognitive Disorders Extra|December 14, 2011
Does the Use of Nursing-Care Services Reduce the Information about Dementia Patients Provided by Their Caregivers?Yu Nakamura, Akira Homma
Geriatrics & Gerontology International|August 23, 2016
Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's diseaseNobuyasu Bando, Yu Nakamura
The Journal of Veterinary Medical Science|April 17, 2018
Tunnel use facilitates handling of ICR mice and decreases experimental variationYu Nakamura, Kaoru Suzuki
Organic Letters|July 1, 2014
Oxidative debenzylation of N-benzyl amides and O-benzyl ethers using alkali metal bromideKatsuhiko Moriyama, Yu Nakamura, Hideo Togo
Pageof 13